Citadel Advisors’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.06M Sell
324,600
-112,900
-26% -$2.19M ﹤0.01% 3801
2025
Q4
$9.41M Sell
437,500
-229,900
-34% -$4.85M ﹤0.01% 3328
2025
Q3
$12.9M Buy
667,400
+294,300
+79% +$5.25M ﹤0.01% 2898
2025
Q2
$6.38M Buy
373,100
+237,500
+175% +$10.1M ﹤0.01% 3708
2025
Q1
$8.65M Sell
135,600
-14,800
-10% -$1.56M ﹤0.01% 3046
2024
Q4
$18.3M Sell
150,400
-17,200
-10% -$2.11M ﹤0.01% 2259
2024
Q3
$20.9M Sell
167,600
-34,600
-17% -$4.78M ﹤0.01% 2006
2024
Q2
$31.9M Sell
202,200
-76,900
-28% -$9.88M 0.01% 1552
2024
Q1
$36.1M Sell
279,100
-245,300
-47% -$30M 0.01% 1479
2023
Q4
$50.6M Buy
524,400
+214,400
+69% +$20.6M 0.01% 1169
2023
Q3
$37.6M Buy
310,000
+92,300
+42% +$10.4M 0.01% 1308
2023
Q2
$24.9M Sell
217,700
-38,000
-15% -$4.9M 0.01% 1663
2023
Q1
$35.2M Buy
255,700
+135,200
+112% +$17.5M 0.01% 1386
2022
Q4
$15.6M Buy
120,500
+38,900
+48% +$4.51M ﹤0.01% 2234
2022
Q3
$9.02M Buy
81,600
+18,100
+29% +$1.82M ﹤0.01% 2919
2022
Q2
$4.76M Sell
63,500
-19,100
-23% -$1.41M ﹤0.01% 3886
2022
Q1
$6.45M Sell
82,600
-103,600
-56% -$7.93M ﹤0.01% 3695
2021
Q4
$16.8M Buy
186,200
+19,400
+12% +$1.66M ﹤0.01% 2251
2021
Q3
$15.4M Sell
166,800
-35,300
-17% -$2.72M ﹤0.01% 2391
2021
Q2
$15.7M Sell
202,100
-134,100
-40% -$10.2M ﹤0.01% 2390
2021
Q1
$25.1M Buy
336,200
+130,200
+63% +$12M 0.01% 1709
2020
Q4
$35.1M Buy
206,000
+17,100
+9% +$2.53M 0.01% 1255
2020
Q3
$26.5M Buy
188,900
+7,100
+4% +$1.08M 0.01% 1332
2020
Q2
$29.1M Sell
181,800
-75,300
-29% -$10.2M 0.01% 1191
2020
Q1
$25.1M Sell
257,100
-210,600
-45% -$24.1M 0.01% 1058
2019
Q4
$60.4M Buy
467,700
+183,900
+65% +$18.6M 0.03% 661
2019
Q3
$21.4M Sell
283,800
-16,600
-6% -$1.96M 0.01% 1402
2019
Q2
$45.6M Buy
300,400
+143,700
+92% +$17.5M 0.02% 781
2019
Q1
$18.7M Sell
156,700
-28,300
-15% -$3.64M 0.01% 1399
2018
Q4
$20.2M Sell
185,000
-22,400
-11% -$2.8M 0.01% 1225
2018
Q3
$33.5M Sell
207,400
-5,900
-3% -$807K 0.01% 1007
2018
Q2
$28.2M Buy
213,300
+135,900
+176% +$12.8M 0.01% 1045
2018
Q1
$5.74M Sell
77,400
-77,800
-50% -$5.19M ﹤0.01% 2323
2017
Q4
$8.63M Sell
155,200
-55,300
-26% -$2.93M 0.01% 1877
2017
Q3
$9.55M Buy
210,500
+128,800
+158% +$5.15M 0.01% 1644
2017
Q2
$2.75M Sell
81,700
-6,400
-7% -$208K ﹤0.01% 2757
2017
Q1
$2.61M Sell
88,100
-79,300
-47% -$2.45M ﹤0.01% 2751
2016
Q4
$4.59M Sell
167,400
-283,000
-63% -$11.4M ﹤0.01% 2098
2016
Q3
$27.7M Buy
450,400
+246,400
+121% +$7.45M 0.03% 687
2016
Q2
$3.89M Buy
204,000
+85,300
+72% +$1.58M ﹤0.01% 2051
2016
Q1
$2.32M Buy
118,700
+68,400
+136% +$1.2M ﹤0.01% 2488
2015
Q4
$1.94M Buy
50,300
+1,300
+3% +$42.2K ﹤0.01% 2773
2015
Q3
$1.57M Sell
49,000
-24,400
-33% -$828K ﹤0.01% 3243
2015
Q2
$2.23M Buy
73,400
+45,500
+163% +$930K ﹤0.01% 2938
2015
Q1
$371K Sell
27,900
-4,300
-13% -$57.3K ﹤0.01% 5356
2014
Q4
$466K Sell
32,200
-10,800
-25% -$183K ﹤0.01% 4825
2014
Q3
$907K Buy
43,000
+12,600
+41% +$284K ﹤0.01% 3829
2014
Q2
$906K Sell
30,400
-600
-2% -$19K ﹤0.01% 3630
2014
Q1
$745K Sell
31,000
-24,900
-45% -$635K ﹤0.01% 3808
2013
Q4
$1.14M Sell
55,900
-34,000
-38% -$1.01M ﹤0.01% 3101
2013
Q3
$4.25M Sell
89,900
-48,700
-35% -$1.88M 0.01% 1697
2013
Q2
$5.27M Buy
+138,600
New +$4.96M 0.01% 1524

Other funds holding SRPT